坦西诺针对耐药结核病:疗效,选择性和潜在的作用机制
Giulia Polinário1, Maiara A B C Rosa1, Débora L Campos1
1Tuberculosis Research Laboratory, School of Pharmaceutical Sciences, São Paulo State University - UNESP Araraquara São Paulo Brazil fernando.pavan@unesp.br.
RSC medicinal chemistry
|October 9, 2025
概括
坦辛I,IIA和密度坦辛对抗耐药结核病具有强大的抗菌活性. 这些天然化合物具有较低的毒性,可以向菌根细胞壁,提供有前途的新治疗途径.
科学领域:
- 自然产品化学 自然产品化学
- 微生物学 微生物学
- 药理学 药理学是指药理学的学科.
背景情况:
- 在*Mycobacterium结核病*中抗菌素耐药性需要新的治疗策略.
- 目前的结核病治疗因耐药性和复杂的治疗方案而面临挑战.
- 自然化合物为新的抗结核药物提供了潜在的来源.
研究的目的:
- 评估坦辛I (TI),坦辛IIA (TIIA) 和加密坦辛 (CPT) 对*Mycobacterium tuberculosis*的抗菌潜力.
- 为了评估这些tanshinones的*in vitro*活性,毒性和光谱.
- 研究它们的作用机制和对抗多药耐药菌株的疗效.
主要方法:
- 最低抑制度 (MIC90) 和细胞毒性指数 (CI50) 的测定.
- 抗微生物频谱测试,与利芬素的组合测试,以及分数抑制度指数 (FICI) 确定.
- 扫描电子显微镜 (SEM) 和全基因组测序 (WGS) 来阐明作用机制.
主要成果:
- TI,TIIA和CPT对*M.结核病*具有强烈的*体外*活性,具有低毒性.
- 观察到TI与利法皮辛结合时具有协同作用.
- SEM揭示了细胞壁的改变,而WGS在耐药菌株中发现了PE_PGRS基因的突变,表明细胞壁的向.
- 化合物对抗多抗药性临床隔离物是有效的.
结论:
- 坦辛I,IIA和加密坦辛是开发抗药性结核病新疗法的有希望的候选者.
- 它们的潜在机制涉及对菌根菌细胞壁结构的调节.
- 进一步研究基于坦辛的治疗方法是有必要的.
更多相关视频
10:29A High-throughput Compatible Assay to Evaluate Drug Efficacy against Macrophage Passaged Mycobacterium tuberculosis
Published on: March 24, 2017
8.3K
09:57Visualization of the Charcoal Agar Resazurin Assay for Semi-quantitative, Medium-throughput Enumeration of Mycobacteria
Published on: December 14, 2016
10.8K
相关概念视频
Pulmonary Tuberculosis V
534
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
534
Pulmonary Tuberculosis IV
474
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
474
Pulmonary Tuberculosis III
931
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
The first classification is based on the development of the disease, and it includes the following categories:
931
Pulmonary Tuberculosis I
827
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
827
Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K
